Q3 2023 Esperion Therapeutics Inc Earnings Call Transcript

Nov 07, 2023 / 01:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Esperion Therapeutics third-quarter 2023 financial results call. (Operator Instructions) Please be advised that today's conference may be recorded.

I would now like to hand the conference over to Alexis Callahan, Head of Investor Relations at Esperion. Please go ahead, Alexis.

Alexis Callahan - Esperion Therapeutics, Inc. - IR

Thank you, operator. Good morning, and welcome to Esperion's third-quarter 2023 earnings conference call. With us today are Sheldon Koenig, President and CEO; and Ben Halladay, CFO. Other members of the executive team will be available for Q&A following our prepared remarks.

I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot